RAN and amyotrophic lateral sclerosis: Third, the isolated target from ALS patient PBMCs is altered in protein composition compared to that from most healthy controls by two metrics: diminution of p62/SQSTM1 and appearance of 17 kDa fragment of Ran GTPase.